Apoptosis Signal-Regulating Kinase 1 Regulates Colitis and Colitis-Associated Tumorigenesis by the Innate Immune Responses

Gastroenterology

Volumn 138, Issue 3, 2010, Pages

  Hayakawa, Yoku ^a   Hirata, Yoshihiro ^a   Nakagawa, Hayato ^a   Sakamoto, Kei ^a,b   Hikiba, Yohko ^b   Otsuka, Motoyuki ^a   Ijichi, Hideaki ^a   Ikenoue, Tsuneo ^a   Tateishi, Keisuke ^a   Akanuma, Masao ^b   Ogura, Keiji ^a   Yoshida, Haruhiko ^a   Ichijo, Hidenori ^a   Omata, Masao ^a   Maeda, Shin ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

ASK1; Colitis; Colitis Associated Cancer; Innate Immunity

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; AZOXYMETHANE; DEXTRAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; CARCINOGENESIS; CELL ISOLATION; CELL PROLIFERATION; CITROBACTER RODENTIUM; COLITIS; COLITIS ASSOCIATED CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENTERITIS; ENTEROBACTERIACEAE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 77249111224     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.015     Document Type: Article

References (42)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
3. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
4. Itzkowitz S.H., and Yio X. Inflammation and cancer, IV: colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287 (2004) G7-G17
5. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
6. Cuenda A., and Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773 (2007) 1358-1375
7. Hommes D.W., Peppelenbosch M.P., and van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (2003) 144-151
8. Van Den Blink B., Ten Hove T., Van Den Brink G.R., et al. From extracellular to intracellular targets, inhibiting MAP kinases in treatment of Crohn's disease. Ann N Y Acad Sci 973 (2002) 349-358
9. Farrell R.J., and LaMont J.T. Microbial factors in inflammatory bowel disease. Gastroenterol Clin North Am 31 (2002) 41-62
10. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
11. Fukata M., Chen A., Vamadevan A.S., et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133 (2007) 1869-1881
12. Ichijo H., Nishida E., Irie K., et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997) 90-94
13. Nishitoh H., Saitoh M., Mochida Y., et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2 (1998) 389-395
14. Takeda K., Matsuzawa A., Nishitoh H., et al. Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation. EMBO Rep 5 (2004) 161-166
15. Matsuzawa A., Saegusa K., Noguchi T., et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6 (2005) 587-592
16. Iriyama T., Takeda K., Nakamura H., et al. ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis. EMBO J 28 (2009) 843-853
17. Tobiume K., Matsuzawa A., Takahashi T., et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2 (2001) 222-228
18. Siegmund B., Fantuzzi G., Rieder F., et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1264-R1273
19. Maeda S., Hsu L.C., Liu H., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
20. Rath H.C., Schultz M., Freitag R., et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 69 (2001) 2277-2285
21. Donnenberg M.S., Tzipori S., McKee M.L., et al. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest 92 (1993) 1418-1424
22. Greten F.R., Arkan M.C., Bollrath J., et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130 (2007) 918-931
23. Park J.M., Greten F.R., Wong A., et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. Immunity 23 (2005) 319-329
24. Izumi Y., Kim-Mitsuyama S., Yoshiyama M., et al. Important role of apoptosis signal-regulating kinase 1 in ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 1877-1883
25. Nishitoh H., Matsuzawa A., Tobiume K., et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16 (2002) 1345-1355
26. Yamaguchi O., Higuchi Y., Hirotani S., et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci U S A 100 (2003) 15883-15888
27. Nakagawa H., Maeda S., Hikiba Y., et al. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 135 (2008) 1311-1321
28. Hommes D., van den Blink B., Plasse T., et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 122 (2002) 7-14
29. Lowenberg M., Verhaar A., van den Blink B., et al. Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease. J Immunol 175 (2005) 2293-2300
30. Schreiber S., Feagan B., D'Haens G., et al. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4 (2006) 325-334
31. ten Hove T., van den Blink B., Pronk I., et al. Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut 50 (2002) 507-512
32. Hollenbach E., Neumann M., Vieth M., et al. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J 18 (2004) 1550-1552
33. Nishimura T., Andoh A., Nishida A., et al. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice. World J Gastroenterol 14 (2008) 5851-5856
34. Assi K., Pillai R., Gomez-Munoz A., et al. The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology 118 (2006) 112-121
35. Chromik A.M., Muller A.M., Korner J., et al. Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice. J Invest Surg 20 (2007) 23-33
36. Segal A.W. How neutrophils kill microbes. Annu Rev Immunol 23 (2005) 197-223
37. Fang F.C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2 (2004) 820-832
38. Saitoh M., Nishitoh H., Fujii M., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17 (1998) 2596-2606
39. Hsu L.C., Park J.M., Zhang K., et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428 (2004) 341-345
40. Greten F.R., Eckmann L., Greten T.F., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
41. Hayakawa Y., Maeda S., Nakagawa H., et al. Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis. J Gastroenterol 44 (2009) 935-943
42. Popivanova B.K., Kitamura K., Wu Y., et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118 (2008) 560-570